Concepedia

Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease

Valéria S. Fernandes, José Ronaldo dos Santos, Anderson H.F.F. Leão, André M. Medeiros, Thieza G. Melo, Geison Souza Izídio, Alícia Cabral, Rosana A. Ribeiro, Vanessa C. Abı́lio, Alessandra Mussi Ribeiro,

Behavioural Brain Research · 2012 · 113 citations · 60 references

DOI

Concepts

References

60

Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease

Erwan Bézard, Sandra Doveró, Caroline Prunier et al. · Journal of Neuroscience · 2001 · 481 citations · Full text

, , +17

Dopamine turnover and glutathione oxidation: implications for Parkinson disease.

Mary Beth Spina, G. Cohen · Proceedings of the National Academy of Sciences · 1989 · 397 citations · Full text

, , +17

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET

Roshan Cools, Elka Stefanova, Roger A. Barker et al. · Brain · 2002 · 396 citations

, , +17

Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration

W. Michael Caudle, Jason R. Richardson, Min Z. Wang et al. · Journal of Neuroscience · 2007 · 389 citations · Full text

, , +17

Planning and spatial working memory in Parkinson's disease.

Robin G. Morris, J.J. Downes, Barbara J. Sahakian et al. · Journal of Neurology Neurosurgery & Psychiatry · 1988 · 364 citations · Full text

, , +17